Advertisement

Hyperlipidemia as a Risk Factor

  • M. Mancini
  • P. Rubba
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 58)

Abstract

Hyperlipidemia plays a key role in the pathogenesis of atherosclerosis and its clinical manifestation (coronary heart disease, stroke, lower limb gangrene etc.). Evidence will be presented from several sources (epidemiological research, pathology, clinical investigation) on the relationship between plasma lipid or lipoprotein abnormalities and atherosclerotic cardiovascular disease.

Keywords

Coronary Heart Disease Plasma Lipoprotein Familial Hypercholesterolemia Familial Hypercholesterolemia Premature Atherosclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. Ross, J.A. Glomset, The pathogenesis of Atherosclerosis (First of two parts), The New England J. Medicine, 295: 369 (1976).CrossRefGoogle Scholar
  2. 2.
    R. Ross, J.A. Glomset, The pathogenesis of Atherosclerosis (Second of two parts), The New England J. Medicine, 295: 420 (1976).CrossRefGoogle Scholar
  3. 3.
    A.C. Onitiri, B. Lewis, H. Bentall, C. Jamieson, J. Wisheart, I. Faris, Lipoprotein concentrations in serum and in biopsy samples of arterial intima - A quantitative comparison, Atherosclerosis, 23: 513 (1976).PubMedCrossRefGoogle Scholar
  4. 4.
    P. Costandinides, Experimental Atherosclerosis, Elsevier, Amsterdam (1965).Google Scholar
  5. 5.
    R.M. Greehalgh, B. Lewis, D.S. Rosengarten, J.S. Calman, I. Mervant, P. Martin, Serum lipids and lipoproteins in peripheral vascular disease, Lancet, 2: 957 (1971).Google Scholar
  6. 6.
    J.L. Goldstein, W.R. Hazzard, H.G. Schrott, E.L. Bierman, A.G. Motulski, Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction, J. Clin. Invest., 52:1533 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    L.A. Carlson, M. Ericsson, Quantitative and qualitative serum lipoprotein analysis. II. Studies in male survivors of myocardial infarction, Atherosclerosis, 21: 417 (1975).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Lewis, A. Chait, C.M. Oakley, I.D.P. Wootton et al., Serum lipoprotein abnormalities in patients with ischemic heart disease: comparison with a control population, Brit. Med. J., 3: 489 (1974).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Panico, E. Farinaro, G. Riccardi, P. Rubba, Lipid and lipoprotein levels in survivors of myocardial infarction, in: ‘International Conference on Atherosclerosis’, L.A. Carlson et al. (eds.), 709, Raven Press, New York (1978).Google Scholar
  10. 10.
    A. Keys, Coronary heart disease in seven countries, Circulation, 41 supplement 1, (1970).Google Scholar
  11. 11.
    A. Keys et al. (eds.), Seven countries. A multivariate analysis of coronary heart disease and death, Harvard University Press, Cambridge Massachusetts (1980).Google Scholar
  12. 12.
    The Pooling Project Research Group, Relationship of blood pressure, serum cholesterol, smoking habit, relative weight to incidence of major coronary events: final report of the Pooling Project, J. Chron. Dis., 31: 201 (1978).CrossRefGoogle Scholar
  13. 13.
    J.D. Brunzell, A. Chait, E.L. Bierman, Pathophysiology of lipoprotein transport, Metabolism, 27: 1109 (1978).PubMedCrossRefGoogle Scholar
  14. 14.
    B. Lewis, M. Mancini, L.A. Carlson, H. Michell et al., Serum lipoproteins in four European communities: a quantitative comparison, Eur. J. Clin. Invest., 8: 165 (1978).PubMedCrossRefGoogle Scholar
  15. 15.
    World Health OrgänizatTion, World Health Statistics Annual 1973–76, vol 1, WHO Geneva (1976).Google Scholar
  16. 16.
    P. Rubba, E. Farinaro, A. Postiglione, P. Strazzullo, P. Oriente, M. Mancini, Multiple lipoprotein abnormalities in primary hyperlipidemia in Naples, in: ‘International conference on Atherosclerosis’, L.A. Carlson et al., (eds.), 117, Raven Press, New York (1978).Google Scholar
  17. 17.
    J. Slack, Risk of ischemic heart disease in familial hyperlipoproteinemias, Lancet, 2: 1380 (1969).PubMedCrossRefGoogle Scholar
  18. 18.
    J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, A.G. Motulsky, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia, J. Clin. Invest., 52: 1544 (1973).PubMedCrossRefGoogle Scholar
  19. 19.
    J.L. Goldstein, M.S. Brown, Lipoprotein receptors, cholesterol metabolism and atherosclerosis, Arch. Pathol., 99: 181 (1975).PubMedGoogle Scholar
  20. 20.
    J. Morganroth, R.I. Levy, D.S. Fredrickson, The biomedical, clinical and genetic features of type III hyperlipoproteinernia, Ann. Int. Med., 82: 158 (1975).PubMedGoogle Scholar
  21. 21.
    G. Weber, Regression of arterial lesions: Facts and problems, in: ‘International Conference of Atherosclerosis’, L.A. Carlson et al., (eds.), 1, Raven Press, New York (1978).Google Scholar
  22. 22.
    R.W. Wissler, D. Vesselinovitch, Animal models of regression, in: ‘Atherosclerosis IV’, G. Schettler, Y. Goto, Y. Hata, G. Kloss, (eds.), 377, Springer Verlag, New York (1977).CrossRefGoogle Scholar
  23. 23.
    R. Barndt, P.W. Blankenhorn, S.H. Brooks, Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients, Ann. Int. Med., 86: 139 (1977).PubMedGoogle Scholar
  24. 24.
    P. Rubba, S. Panico, F.R. Piantadosi, A. Postiglione, M., Mancini, Early signs of peripheral atherosclerosis of the lower limbs in asymptomatic primary hyperlipoproteinemia, Artery, 6: 59 (1979).Google Scholar
  25. 25.
    A. Postiglione, P. Rubba, N. Scarpato, A. Iannuzzi, M. Mancini, Increased blood flow to lower limbs in two patients with familial hypercholesterolemia, Atherosclerosis, in press.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • M. Mancini
    • 1
  • P. Rubba
    • 1
  1. 1.Center for Arteriosclerosis and Metabolic Disease Semiotica Mecica, 2nd Faculty of MedicineUniversity of NaplesNaplesItaly

Personalised recommendations